SB
Therapeutic Areas
X-gen Pharmaceuticals DJB Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Portfolio Expansion | Various Therapeutic Categories | Approved/Commercial |
| Olanzapine for Injection | Psychiatric disorders | Commercial |
| Edaravone Injection | Amyotrophic Lateral Sclerosis (ALS) | Commercial |
Leadership Team at X-gen Pharmaceuticals DJB
JR
J. Robin Liles
Chief Operating Officer
CL
Catherine Liles
Chief Administrative Officer & Treasurer
EV
Ed Vanderbeck
President